Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma
Jason Adhikaree(University of Nottingham), Poulam M. Patel(University of Nottingham)
Cited by 65
Related Papers
Tumour‐mediated disruption of dendritic cell function: Inhibiting the MEK1/2‐p44/42 axis restores IL‐12 production and Th1‐generation
|International Journal of Cancer|2008|38